Abstract:Background: There is increasing evidence that protein ubiquitination plays crucial roles in adaptive immune response by regulating the function of T cells. Zinc finger protein 91 (ZFP91), as an E3 ubiquitin (Ub) ligase, has been shown to be associated with the proliferation and activation of mouse derived tumor infiltrating lymphocytes. However, whether it functions in human derived T cells and the underlying mechanism still need further exploration. Methods: We used lentivirus infection with H9 cell lines and human primary T cells to reduce ZFP91 expression. Flow cytometry and cck-8 experiments were used to compare the changes of T cell proliferation capacity before and after ZFP91 expression decreased. The expression of granzyme B and IFN-γ was detected by flow cytometry to compare the changes of T cell function. By purifying the recombinant ZFP91 protein, observe whether phase separation will occur in ZFP91, and the effects of protein concentration, salt concentration and temperature changes on phase separation phenomenon. By over expression ZFP91 in Hela cells, observe whether phase separation of ZFP91 occurs intracellularly. The interaction protein G6PD was identified by mass spectrometry analysis, and the regulatory relationship between them was verified by WB. Comparison of NADPH production before and after ZFP91 expression reduction was determined by glutathione peroxidase assay kit. The glycolytic ability of T cells before and after the reduction of ZFP91 expression was compared by lactic acid detection kit and Seahorse experiment. Results: We have verified the function of ZFP91 in H9 and human primary T cells. Compare with the control group, the T cell proliferation ability and the granzyme B, IFN- γ secretion ability of ZFP91 knockdown group enhanced significantly. The purified recombinant ZFP91 protein can separate into dynamic droplets under near-physiological conditions. After overexpressing ZFP91 in Hela cells, phase separation can also be observed in intact cells. In mass spectrometry analysis, we found that ZFP91 interacts with the key rate-limiting enzyme glucose-6-phosphate dehydrogenase (G6PD) of the pentose phosphate pathway (PPP). Therefore, we continued to detect the metabolite of the PPP pathway, nicotinamide adenine dinucleotide phosphate (NADPH), and found that the level of NADPH in the ZFP91 knockdown group increased. In addition, we measured the lactic acid level of T cells and found that compared to the control group, the ZFP91 knockdown group had a decreased intracellular lactic acid level, basal glycolytic capacity and maximum glycolytic capacity. Conclusions: Our results show that ZFP91, as a functional inhibitory molecule of T cells, is able to undergo phase separation and influence T cell function by regulating the G6PD-PPP pathway, which suggest it may serve as a potential target to regulate T cell’s proliferation and function. This study was supported by NSFC 82272102.

ZFP91 disturbs metabolic fitness and antitumor activity of tumor-infiltrating T cells

Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression

P.09: Phase Separation Ability of ZFP91 and Its Regulation on T Cell Metabolic Pathways

ZFP91 is Required for the Maintenance of Regulatory T Cell Homeostasis and Function.

Zinc finger protein 91 accelerates tumour progression by activating -catenin signalling in pancreatic cancer

ZFP64 drives glycolysis-mediated stem cell-like properties and tumorigenesis in breast cancer

ZNF281 inhibits mitochondrial biogenesis to facilitate metastasis of hepatocellular carcinoma

DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis

Zinc-finger antiviral protein acts as a tumor suppressor in colorectal cancer

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

Zinc Finger Protein 91 (ZFP91) Activates HIF-1α Via NF-κB/p65 to Promote Proliferation and Tumorigenesis of Colon Cancer.

Cancer Mediates Effector T Cell Dysfunction by Targeting Micrornas and EZH2 Via Glycolysis Restriction (TUM9P.1007)

Zinc dampens antitumor immunity by promoting Foxp3+ regulatory T cells

Metabolic stress‐induced reciprocal loop of long noncoding RNA ZFAS1 and ZEB1 promotes epithelial–mesenchymal transition and metastasis of pancreatic cancer cells

ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer

Inactivation of Endothelial ZEB1 Impedes Tumor Progression and Sensitizes Tumors to Conventional Therapies.

ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress

CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors

ATPIF1 Inactivation Promotes Antitumor Immunity Through Metabolic Reprogramming of CD8+ T Cells

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity

ZFP91 promotes cell proliferation and inhibits cell apoptosis in AML via inhibiting the proteasome-dependent degradation of RIP1